**To the Editor:** Fluoroquinolone (FQ)-resistant *Salmonella* has been isolated from patients in Taiwan ([@R1]*--*[@R7]). Recently, a report further indicated that several patients were infected with *Salmonella enterica* serovar Schwarzengrund with high-level FQ resistance ([@R1]). *S*. Schwarzengrund has never been isolated from food animals in Taiwan.

We report the isolation of FQ-resistant strains from pork and broiler carcasses sampled from 2000 to 2003: 27 in 2000, 3 in 2001, 4 in 2002, and 2 in 2003. These isolates made up 18.85% of the 191 *Salmonella* strains obtained from pork and broiler carcasses in the study period. Of these isolates, 16 FQ-resistant *S*. Schwarzengrund strains were further analyzed to elucidate the possible mechanism of FQ resistance. Ciprofloxacin MIC levels in these isolates ranged from 4 to 16 μg/mL, and all had high-level nalidixic acid resistance (\>1,024 μg/mL). All of the 16 investigated strains displayed mutations possibly associated with high-level FQ resistance. The mutation sites included 2 sites (Ser83Phe and Asp87Gly) in the quinolone resistance--determining region (QRDR) of *gyrA*, 2 sites (Thr57Ser and Ser80Arg) in the QRDR of *parC*, and 1 site (Ser458Pro) in the QRDR of *parE*, respectively. Four strains had mutations in the QRDR of *gyrA* and *parC* only but not in the QRDR of *parE* ([Table](#T1){ref-type="table"}).

###### Characteristics of ciprofloxacin-resistant *Salmonella enterica* serovar Schwarzengrund strains from carcasses\*†

  Strain no.   Origin\*   Year isolated   Antimicrobial drug resistance profile   Quinolone MICs (μg/mL)   Substitutions in QRDR‡                                                       
  ------------ ---------- --------------- --------------------------------------- ------------------------ ------------------------ ---- ---- -------------------- -------------------- -----------
  A5           B, M       2000            CmSxtTc                                 1,024                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A16          P, E       2000            ApCmNSxtTc                              2,048                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A17          P, E       2000            ApCmNSxtTc                              2,048                    512                      32   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A18          P, E       2000            ApCmNSxtTc                              2,048                    512                      32   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A19          P, E       2000            ApCmCnNSxtTc                            1,024                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A20          P, E       2000            ApCmNSxtTc                              2,048                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A29          B, S       2000            CmNSxtTc                                1,024                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A36          B, S       2000            ApCmSxtTc                               1,024                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A41          P, S       2000            ApCmCnNSxtTc                            1,024                    512                      32   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A45          P, S       2000            ApCmNSxtTc                              1,024                    512                      32   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   
  A51          P, S       2000            ApCmCnNSxtTc                            1,024                    512                      16   4    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   
  A56          B, M       2000            ApCmCnNSxtTc                            2,048                    512                      64   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   
  A61          P, S       2000            CmSxtTc                                 1,024                    512                      32   8    Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  A62          P, S       2000            ApCmCnSxtTc                             2,048                    512                      64   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   
  B16          P, E       2001            ApCmCnCroTc                             2,048                    512                      32   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro
  B73          P, N       2003            ApCmCnNSxtTc                            2,048                    512                      32   16   Ser83Phe; Asp87Gly   Thr57Ser; Ser80Arg   Ser458Pro

\*QRDR, quinolone resistance--determining region; B, broiler; M, middle Taiwan; P, pork; E, east Taiwan; S, south Taiwan; N, north Taiwan. †Antimicrobial agents are ampicillin (Ap), chloramphenicol (Cm), ciprofloxacin (CIP), enrofloxacin (ENR), flumequine (FLU), gentamicin (Cn), ceftriaxone (Cro), nalidixic acid (NAL),neomycin (N), trimethoprim/sulfamethoxazole (Sxt), and tetracycline (Tc). ‡No *gyrB* substitutions were detected.

In conclusion, high-level FQ resistance was detected in *S*. Schwarzengrund isolated from pork and chicken in Taiwan. Specific mutation sites of *gyrA*, *parC*, and *parE* were associated with high-level FQ resistance in all the isolates investigated. Our results warrant further investigation of the public health consequences of FQ use in food animals in Taiwan.
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